The team then conducted mouse studies on the new drug and showed that WBZ_4 maintained the anticancer activity of imatinib but is less cardiotoxic.

• 研究小组随后进行的小鼠研究新的药物，并表明wbz_4保持着抗癌活性的伊马替尼，但较少的心脏。